Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception

Human Reproduction

Volumn 30, Issue 7, 2015, Pages 1580-1588

  Kaislasuo, Janina ^a   Heikinheimo, Oskari ^a   Lähteenmäki, Pekka ^a   Suhonen, Satu ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b City of Helsinki   (Finland)

Author keywords

intrauterine contraception; IUD; LNG IUS; nulligravid; nulliparous

Indexed keywords

LEVONORGESTREL; CONTRACEPTIVE AGENT;

ADULT; AMENORRHEA; ARTICLE; COHORT ANALYSIS; COPPER INTRAUTERINE DEVICE; DYSMENORRHEA; DYSPAREUNIA; ECHOGRAPHY; FEMALE; HUMAN; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MAJOR CLINICAL STUDY; MENSTRUATION; NULLIGRAVIDA; NULLIPARA; OBESITY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PILOT STUDY; PROSPECTIVE STUDY; SMOKING; UTERUS CAVITY; ADOLESCENT; ADVERSE EFFECTS; FOLLOW UP; INTRAUTERINE CONTRACEPTIVE DEVICE; PAIN; PHYSIOLOGY; UTERINE HEMORRHAGE; UTERUS; YOUNG ADULT;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAUTERINE DEVICES, COPPER; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENSTRUATION; PAIN; PILOT PROJECTS; UTERINE HEMORRHAGE; UTERUS; YOUNG ADULT;

EID: 84936818655     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev102     Document Type: Article

References (28)

1. American Academy of Pediatrics. Policy Statement. Contraception for adolescents. Pediatrics 2014;134:e1244-e1256.
2. American College of Obstetricians and Gynecologists. Adolescents and long-acting reversible contraception: implants and intrauterine devices. Committee Opinion No. 539. Obstet Gynecol 2012;120:983-988.
3. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (NovaT) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56-72.
4. Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17, 360 users. BJOG 2000;107:335-339.
5. Bahamondes MV, Hidalgo MM, Bahamondes L, Monteiro I. Ease of insertion and clinical performance of the levonorgestrel-releasing system in nulligravidas. Contraception 2011;84:e11-e16.
6. Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1986; 34:253-260.
7. Benacerraf BR, Shipp TD, Bromley B. Three-dimensional ultrasound detection of abnormally located intrauterine contraceptive devices, which are the source of pelvic pain and abnormal bleeding. Ultrasound Obstet Gynecol 2009;34:110-115.
8. Bjarnason NH, Jorgensen HL, Byrjalsen I, Alexandersen P, Christiansen C. The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy. Climacteric 2007;10:480-490.
9. Canteiro R, Bahamondes MV, dos Santos Fernandes A, Espejo-Arce X, Marchi NM, Bahamondes L. Length of the endometrial cavity as measured by uterine sounding and ultrasonography in women of different parities. Contraception 2010;81:515-519.
10. Diedrich JT, Desai S, Zhao Q, Secura G, Madden T, Peipert JF. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. Am J Obstet Gynecol 2015;212: 50. e1-50. e8.
11. Gadelha Da Costa A, Filho FM, Ferreira AC, Spara P, Mauad FM. Uterine volume in adolescents. Ultrasound Med Biol 2004;30:7-10.
12. Hubacher D. Copper intrauterine device use by nulliparous women: review of side effects. Contraception 2007;75(6 Suppl):S8-11.
13. Jensen J, Nelson A, Costales A. Subject and clinician experience with the levonorgestrel-releasing intrauterine system. Contraception 2008;77: 22-29.
14. Johnson J, Whitaker AH. Adolescent smoking, weight changes, and binge-purge behavior: associations with secondary amenorrhea. Am J Public Health 1992;82:47-54.
15. Jones RL, Critchley HO. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery. Hum Reprod 2000;15(Suppl 3):162-172.
16. Kaislasuo J, Heikinheimo O, Lähteenmäki P, Suhonen S. Predicting painful or difficult intrauterine device insertion in nulligravid women. Obstet Gynecol 2014;124(2 Pt 1):345-353.
17. Khorram O, Han G, Magee T. Cigarette smoke inhibits endometrial epithelial cell proliferation through a nitric oxide-mediated pathway. Fertil Steril 2010; 93:257-263.
18. Kurz KH, Tadesse E, Haspels AA. In vivo measurements of uterine cavities in 795 women of fertile age. Contraception 1984;29:495-510.
19. Madden T, McNicholas C, Zhao Q, Secura GM, Eisenberg DL, Peipert JF. Association of age and parity with intrauterine device expulsion. Obstet Gynecol 2014;124:718-726.
20. Marions L, Lö vkvist L, Taube A, Johansson M, Dalvik H, Overlie I. Use of the levonorgestrel-releasing intrauterine system in nulliparous women-a non-interventional study in Sweden. Eur J Contracept Reprod Health Care 2011;16:126-134.
21. National Institute for Health and Care Excellence. Clinical guideline 30. Long-Acting Reversible Contraception (update). September 2014.
22. Nilsson CG, Haukkamaa M, Vierola H, Luukkainen T. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin Endocrinol 1982;17:529-536.
23. O'Neil-Callahan M, Peipert JF, Zhao Q, Madden T, Secura G. Twentyfour-month continuation of reversible contraception. Obstet Gynecol 2013;122:1083-1091.
24. Shipp T, Bromley B, Benacerraf BR. The width of the uterine cavity is narrower in patients with an embedded intrauterine device (IUD) compared to a normally positioned IUD. J Ultrasound Med 2010; 29:1453-1456.
25. Siasos G, TsigkouV, Kokkou E, OikonomouE, VavuranakisM, VlachopoulosC, Verveniotis A, Limperi M, Genimata V, Papavassiliou AGet al. Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches. Curr Med Chem 2014;21:3936-3948.
26. Suhonen S, Haukkamaa M, JakobssonT, Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 2004; 69:407-412.
27. Suvisaari J, Lähteenmäki P. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception 1996;54: 201-208.
28. WildemeerschD, PettA, Jandi S, Hasskamp T, Rowe P, VrijensM. Precision intrauterine contraception may significantly increase continuation of use: a reviewof long-termclinical experiencewith frameless copper-releasing intrauterine contraception devices. Int J Womens Health 2013;5: 215-225.